Clinical Trials Logo

Endothelial Progenitor Cells clinical trials

View clinical trials related to Endothelial Progenitor Cells.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05857085 Completed - Clinical trials for Diabetes Mellitus, Type 1

Novel Therapeutics and Endothelial Dysfunction in T1DM Patients

ENDIS
Start date: December 15, 2021
Phase: Phase 4
Study type: Interventional

The aim of study is impact of additional treatment with new antidiabetic drugs (semaglutide or empagliflozine) compared to control group in T1DM patients - impact on endothelial function measured by FMD and FPF, arterial stiffness - measured by PWV, inflammatory biomarkers, markers of oxidative stress and endothelial progenitor cells (CD 34+/VDRL2, CD 133+/VDRL2) and correlation with glucovariability or time in range, measured with CGM system.

NCT ID: NCT02975518 Completed - Clinical trials for Coronary Artery Disease

Tracking Endothelial Cells in Arterial Injury

Start date: December 2015
Phase: N/A
Study type: Interventional

We plan to track the migratory behaviour of culture-expanded enothelial outgrowth cells in the context of vascular injury sustained during elective coronary angiography. We will use Flouro-deoxyglucose-labelling and PET-CT to track the endothelial cells.